Home Search Contacts Help
ABPI - The Association of the British Pharmaceutical Industry
 
Facts & Statistics from the pharmaceutical industry

A global industry

Pharmaceuticals are one of Britain’s leading manufacturing sectors, bringing in a trade surplus of £4.3 billion in 2007. The value of UK pharmaceutical exports in 2007 was £14.6 billion, more than £235,000 per employee. Yet we are low in the league of medicines expenditure: we spend much less than many of our European neighbours on the medicines we use. But our two largest pharmaceutical companies are among the most successful in the world. In a global industry such as pharmaceuticals, it is important to be in the Big League. An analysis of the world’s top 100 medicines reveals that, after the USA, Britain’s pharmaceutical companies’ market share is more than all its European competitors combined. Despite this success, British doctors are still reluctant to prescribe new medicines – clinicians in other countries are far more likely to prescribe medicines that have come on to the market in the past five years.


 
1. World trade in pharmaceuticals, 2007
Exports £ Imports £ Balance £
Switzerland 20,206 9,336 10,870
Ireland 9,664 1,520 8,144
Germany 24,395 18,810 5,586
UK 14,567 10,291 4,276
France 13,675 10,135 3,540
Sweden 4,726 1,731 2,995
Netherlands 7,439 7,276 163
Italy 7,607 8,466 -859
Spain 4,142 5,227 -1,085
Japan 1,736 4,625 -2,889
USA 17,491 35,801 -18,310
Source
Efpia,
JPMA,
US Census Bureau,
UK Customs and Excise
 
2. Annual medicines expenditure per person, 2008
Notes
£ per person
Includes prescription and hospital medicines
Source
IMS World Review
United Nations, World Population Prospects
Office for National Statistics
 
3. Spend on medicines as a percentage of GDP in various countries, 2007
Notes
Includes prescription and hospital medicines
Source
IMS World Review
OECD http://www.oecd.org/std/nahome.htm
Office for National Statistics
 
4. Top world pharmaceutical corporations, 2007
Country Sales £ Growth* % Market
share** %
Pfizer USA 22,292 -2 6.7
GlaxoSmithKline UK 18,847 1 5.6
Novartis SWI 17,154 9 5.1
Sanofi Aventis FRA 16,788 8 5.0
Astrazeneca UK 15,010 9 4.5
Johnson & Johnson USA 14,478 5 4.3
Roche SWI 13,814 18 4.1
Merck & Co USA 13,631 8 4.1
Abbott USA 9,570 8 2.9
Lilly USA 8,335 13 2.5
Leading 10 149,920 6 44.9
Amgen USA 8,188 1 2.5
Wyeth USA 7,949 8 2.4
Bayer GER 7,020 13 2.1
Bristol-Myers Squibb USA 6,519 6 2.0
Boehringer Ingelheim GER 6,277 11 1.9
Schering-Plough USA 6,181 10 1.9
Takeda JAP 5,479 9 1.6
Teva ISR 5,300 12 1.6
Novo Nordisk DEN 3,336 18 1.0
Daiichi Sankyo JAP 2,925 7 0.9
Leading 20 209,093 7 62.6
Notes
By worldwide sales value
* calculated in US$
** IMS audited markets
Source
IMS
 
5. Sales share of the world's top 100 prescription medicines 2007
Source
IMS
 
6. Market share of medicines launched in last 5 years - 2007
Notes
Products launched between 2002 and 2007
Primary and hospital markets
Source
IMS World Review
 
7. UK Pharmaceutical & Retail Price Indices
Source
ABPI calculation using ONS data

back to contents

 
Previous Page | Print Page | Top of Page
Copyright © ABPI - The Association of the British Pharmaceutical Industry Terms and Conditions | Privacy Policy